# Prospective Study to Evaluate the Blood Kinetics of Immune Cells and Immunosuppressive Cytokines After Exposure to an Immunity Checkpoint Inhibitor (ICI): Study of the Impact of Chemotherapy

> **NCT04487457** · — · COMPLETED · sponsor: **University Hospital, Tours** · enrollment: 31 (actual)

## Conditions studied

- Non Small Cell Lung Cancer
- Bladder Cancer
- ENT Cancer

## Interventions

- **OTHER:** Blood samples

## Key facts

- **NCT ID:** NCT04487457
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-03
- **Primary completion:** 2022-09-29
- **Final completion:** 2022-09-29
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2023-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04487457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04487457, "Prospective Study to Evaluate the Blood Kinetics of Immune Cells and Immunosuppressive Cytokines After Exposure to an Immunity Checkpoint Inhibitor (ICI): Study of the Impact of Chemotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04487457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*